This post was just published on ZYX Buy Change Alert. New buy zone for those not in ARNA is $20.33 to $22.78. Maximum position is 20% of the full core position size. New target zone without a buyout is $32 to $34. In the event of a buyout, a price in the
This post was published on ZYX Buy Change Alert. ARNA is long from $16.20. It is trading at $25 as of this writing. The company announced positive Phase 2 results for Ralinepag for the treatment of pulmonary arterial hypertension. The gains are not as some are mistakenly thinking. The stock was
The January Effect offers an opportunity to potentially make about 30% in three months. It is a phenomenon that makes prices of certain stocks rise more in January than the market averages. Over the last 30 years, we have made money from the January Effect about 75% of the time,
The U.S. Food and Drug Administration (FDA) has approved the first obesity drug in 15 years. The drug is lorcaserin, dubbed Belviq, from Arena Pharmaceuticals (ARNA). The drug works by affecting the area of the brain that regulates metabolism. The issue with weight loss drugs has not been efficacy, rather
This post was published earlier on ZYX BuyChange Alert OREX is a sympathy play with ARNA. FDA has just approved ARNA weight loss drug. The risk is very high and this trade is only for aggressive investors. Buy zone is $3.90 -4.61. Stop zone is 3.43-3.73. Target zone is $6-7.50. This is